image
Consumer Defensive - Packaged Foods - NYSE - US
$ 40.34
2.28 %
$ 769 M
Market Cap
14.25
P/E
1. INTRINSIC VALUE

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products.[ Read More ]

The intrinsic value of one USNA stock under the base case scenario is HIDDEN Compared to the current market price of 40.3 USD, USANA Health Sciences, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart USNA

image
FINANCIALS
921 M REVENUE
-7.77%
93.1 M OPERATING INCOME
-13.51%
63.8 M NET INCOME
-8.02%
70.6 M OPERATING CASH FLOW
-32.01%
-12 M INVESTING CASH FLOW
3.19%
-14.2 M FINANCING CASH FLOW
52.68%
200 M REVENUE
-5.94%
15.6 M OPERATING INCOME
-12.55%
10.6 M NET INCOME
1.68%
29.5 M OPERATING CASH FLOW
269.64%
-2.34 M INVESTING CASH FLOW
-51.23%
-78 K FINANCING CASH FLOW
94.24%
Balance Sheet Decomposition USANA Health Sciences, Inc.
image
Current Assets 418 M
Cash & Short-Term Investments 330 M
Receivables 7.2 M
Other Current Assets 80.1 M
Non-Current Assets 215 M
Long-Term Investments 0
PP&E 99.8 M
Other Non-Current Assets 115 M
Current Liabilities 119 M
Accounts Payable 10.1 M
Short-Term Debt 8.06 M
Other Current Liabilities 101 M
Non-Current Liabilities 16.7 M
Long-Term Debt 0
Other Non-Current Liabilities 16.7 M
EFFICIENCY
Earnings Waterfall USANA Health Sciences, Inc.
image
Revenue 921 M
Cost Of Revenue 177 M
Gross Profit 744 M
Operating Expenses 651 M
Operating Income 93.1 M
Other Expenses 29.3 M
Net Income 63.8 M
RATIOS
80.82% GROSS MARGIN
80.82%
10.11% OPERATING MARGIN
10.11%
6.93% NET MARGIN
6.93%
12.83% ROE
12.83%
10.08% ROA
10.08%
11.64% ROIC
11.64%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis USANA Health Sciences, Inc.
image
Net Income 63.8 M
Depreciation & Amortization 20.4 M
Capital Expenditures -14.5 M
Stock-Based Compensation 14.6 M
Change in Working Capital -28 M
Others -27.3 M
Free Cash Flow 56.1 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets USANA Health Sciences, Inc.
image
Wall Street analysts predict an average 1-year price target for USNA of $39.7 , with forecasts ranging from a low of $35 to a high of $46 .
USNA Lowest Price Target Wall Street Target
35 USD -13.24%
USNA Average Price Target Wall Street Target
39.7 USD -1.67%
USNA Highest Price Target Wall Street Target
46 USD 14.03%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership USANA Health Sciences, Inc.
image
Sold
0-3 MONTHS
25.5 K USD 1
3-6 MONTHS
1.34 M USD 4
6-9 MONTHS
2.16 M USD 11
9-12 MONTHS
15.5 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Nov 04, 2024
Sell 25.5 K USD
FULLER GILBERT A
Director
- 675
37.7144 USD
3 months ago
Aug 13, 2024
Sell 240 K USD
Jones Paul A.
CHIEF PEOPLE OFFICER
- 6266
38.3796 USD
3 months ago
Aug 07, 2024
Sell 26.8 K USD
FULLER GILBERT A
Director
- 674
39.6935 USD
3 months ago
Jul 31, 2024
Sell 44.4 K USD
Fleming John Turman
Director
- 1000
44.43 USD
5 months ago
Jun 12, 2024
Sell 105 K USD
WENTZ MYRON W
10 percent owner
- 2202
47.79 USD
5 months ago
Jun 14, 2024
Sell 608 K USD
WENTZ MYRON W
10 percent owner
- 13496
45.03 USD
5 months ago
Jun 07, 2024
Sell 180 K USD
WENTZ MYRON W
10 percent owner
- 3700
48.61 USD
5 months ago
May 22, 2024
Sell 132 K USD
Jones Paul A.
CHIEF PEOPLE OFFICER
- 2714
48.6601 USD
6 months ago
May 07, 2024
Sell 233 K USD
IIEKKING G DOUG
CHIEF FINANCIAL OFFICER
- 5198
44.7627 USD
6 months ago
May 07, 2024
Sell 21.8 K USD
FULLER GILBERT A
Director
- 490
44.589 USD
6 months ago
May 02, 2024
Sell 179 K USD
Macuga Daniel A.
CHIEF COMMUNICATIONS OFFICER
- 3791
47.1424 USD
8 months ago
Mar 11, 2024
Sell 540 K USD
Guest Kevin
EXEC. CHAIRMAN OF THE BOARD
- 11011
49 USD
8 months ago
Mar 08, 2024
Sell 257 K USD
Noot Walter
CHIEF OPERATING OFFICER
- 5240
49.05 USD
8 months ago
Mar 06, 2024
Sell 179 K USD
Neidig Brent
CO. & MAN. DIR. OF CHINA
- 3810
46.999 USD
8 months ago
Mar 05, 2024
Sell 184 K USD
SINNOTT ROBERT A
CHIEF SCIENTIFIC OFFICER
- 3945
46.555 USD
8 months ago
Mar 04, 2024
Sell 14.7 K USD
Fleming John Turman
Director
- 300
48.9882 USD
8 months ago
Mar 04, 2024
Sell 24.1 K USD
FULLER GILBERT A
Director
- 491
49.0748 USD
8 months ago
Feb 29, 2024
Sell 23.4 K USD
Pelosi Peggie
Director
- 485
48.146 USD
8 months ago
Mar 01, 2024
Sell 72.1 K USD
Macuga Daniel A.
CHIEF COMMUNICATIONS OFFICER
- 1500
48.08 USD
8 months ago
Feb 29, 2024
Sell 206 K USD
Mulham David Mulham
CHIEF SALES OFFICER
- 4311
47.755 USD
8 months ago
Feb 29, 2024
Sell 232 K USD
Foukas Joshua
CHIEF LEGAL OFFICER
- 4847
47.913 USD
11 months ago
Dec 12, 2023
Sell 15.5 K USD
Fleming John Turman
Director
- 312
49.7272 USD
1 year ago
Nov 03, 2023
Sell 22.5 K USD
FULLER GILBERT A
Director
- 490
46.0128 USD
1 year ago
Aug 17, 2023
Sell 59.4 K USD
Winssinger Frederic J
Director
- 930
63.8411 USD
1 year ago
Aug 15, 2023
Sell 141 K USD
Mulham David Mulham
CHIEF SALES OFFICER
- 2159
65.3389 USD
1 year ago
Aug 11, 2023
Sell 71.6 K USD
Mulham David Mulham
CHIEF SALES OFFICER
- 1080
66.2825 USD
1 year ago
Aug 01, 2023
Sell 17.1 K USD
FULLER GILBERT A
Director
- 265
64.4348 USD
1 year ago
Jul 31, 2023
Sell 14.7 K USD
FULLER GILBERT A
Director
- 226
65.012 USD
1 year ago
Jul 31, 2023
Sell 218 K USD
Mulham David Mulham
CHIEF SALES OFFICER
- 3354
65 USD
1 year ago
Jul 28, 2023
Sell 239 K USD
Jones Paul A.
CHIEF PEOPLE OFFICER
- 3682
65 USD
1 year ago
Jul 27, 2023
Sell 39.8 K USD
Ding Xia
Director
- 606
65.5994 USD
1 year ago
Jun 15, 2023
Sell 95 K USD
Mulham David Mulham
CHIEF SALES OFFICER
- 1557
61 USD
1 year ago
Jun 14, 2023
Sell 140 K USD
Macuga Daniel A.
CHIEF COMMUNICATIONS OFFICER
- 2234
62.88 USD
1 year ago
May 08, 2023
Sell 811 K USD
Brown Jim
PRESIDENT
- 12202
66.4793 USD
1 year ago
May 05, 2023
Sell 180 K USD
Neidig Brent
CO & MAN. DIR. OF CHINA
- 2694
66.9596 USD
1 year ago
May 05, 2023
Sell 83.8 K USD
Fleming John Turman
Director
- 1250
67.0432 USD
1 year ago
Apr 28, 2023
Sell 76.7 K USD
Mulham David Mulham
CHIEF SALES OFFICER
- 1138
67.3984 USD
1 year ago
Apr 28, 2023
Sell 165 K USD
Nixon J Scott
Director
- 2450
67.2977 USD
1 year ago
Apr 28, 2023
Sell 27.1 K USD
FULLER GILBERT A
Director
- 404
67.0504 USD
1 year ago
Apr 27, 2023
Sell 135 K USD
Winssinger Frederic J
Director
- 2000
67.2542 USD
1 year ago
Mar 07, 2023
Sell 319 K USD
Guest Kevin
CHIEF EXECUTIVE OFFICER
- 5297
60.1541 USD
1 year ago
Feb 22, 2023
Sell 2.43 K USD
Guest Kevin
CHIEF EXECUTIVE OFFICER
- 40
60.7611 USD
1 year ago
Feb 22, 2023
Sell 799 K USD
Guest Kevin
CHIEF EXECUTIVE OFFICER
- 13248
60.2834 USD
1 year ago
Feb 17, 2023
Sell 187 K USD
Macuga Daniel A.
CHIEF COMMUNICATIONS OFFICER
- 3012
62.22 USD
1 year ago
Feb 16, 2023
Sell 25 K USD
FULLER GILBERT A
Director
- 404
61.85 USD
1 year ago
Feb 16, 2023
Sell 230 K USD
Foukas Joshua
CHIEF LEGAL OFFICER
- 3771
61.01 USD
1 year ago
Feb 15, 2023
Sell 329 K USD
IIEKKING G DOUG
CHIEF FINANCIAL OFFICER
- 5338
61.7055 USD
1 year ago
Feb 15, 2023
Sell 248 K USD
Noot Walter
CHIEF OPERATING OFFICER
- 4014
61.6689 USD
1 year ago
Feb 10, 2023
Sell 367 K USD
SINNOTT ROBERT A
CHIEF SCIENTIFIC OFFICER
- 6013
61.0024 USD
1 year ago
Feb 09, 2023
Sell 116 K USD
Neidig Brent
CO & MAN. DIR. OF CHINA
- 1872
61.8934 USD
1 year ago
Dec 05, 2022
Sell 79.5 K USD
Macuga Daniel A.
director: CHIEF COMMUNICATIONS OFFICER
- 1474
53.9176 USD
2 years ago
Nov 08, 2022
Sell 21.1 K USD
FULLER GILBERT A
Director
- 404
52.11 USD
2 years ago
Aug 01, 2022
Sell 206 K USD
IIEKKING G DOUG
CHIEF FINANCIAL OFFICER
- 2924
70.5059 USD
2 years ago
Aug 16, 2022
Sell 17.9 K USD
Foukas Joshua
director: CHIEF LEGAL OFFICER
- 248
72.04 USD
2 years ago
Aug 15, 2022
Sell 352 K USD
Jones Paul A.
director: CHIEF PEOPLE OFFICER
- 5029
70 USD
2 years ago
Aug 01, 2022
Sell 76.6 K USD
IIEKKING G DOUG
director: CHIEF FINANCIAL OFFICER
- 1086
70.5059 USD
2 years ago
Jul 29, 2022
Sell 28.3 K USD
FULLER GILBERT A
director:
- 404
70 USD
2 years ago
Jun 16, 2022
Sell 99.3 K USD
Neidig Brent
director: CO & MAN. DIR. OF CHINA
- 1400
70.93 USD
2 years ago
May 20, 2022
Sell 21.3 K USD
FULLER GILBERT A
director:
- 312
68.25 USD
2 years ago
Mar 02, 2022
Sell 297 K USD
Foukas Joshua
director: CHIEF LEGAL OFFICER
- 3303
89.9283 USD
2 years ago
Feb 14, 2022
Sell 106 K USD
Noot Walter
Chief Operating Officer
- 1153
92.0237 USD
2 years ago
Feb 15, 2022
Sell 73.8 K USD
Noot Walter
Chief Operating Officer
- 811
91 USD
2 years ago
Feb 16, 2022
Sell 170 K USD
Noot Walter
Chief Operating Officer
- 1885
90.0409 USD
2 years ago
Feb 15, 2022
Sell 28 K USD
FULLER GILBERT A
Director
- 312
89.6224 USD
7. News
USANA Named Top Manufacturer in Utah for Third Time SALT LAKE CITY , Nov. 12, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, was recently awarded Manufacturer of the Year for the third consecutive year by the Utah Manufacturers Association in the "mega-sized (500+ employees) companies" category. To learn more about USANA and its commitment to quality, please visit USANA.com. prnewswire.com - 5 days ago
USANA Executive Chairman Kevin Guest Celebrates Gratitude Month SALT LAKE CITY , Nov. 1, 2024 /PRNewswire/ -- This November, a multinational leader is encouraging people everywhere to celebrate National Gratitude Month and experience the profound impact gratitude has on health and happiness. From enhancing psychological well-being to boosting physical health, gratitude has a transformative effect that can change lives in deeply meaningful ways. prnewswire.com - 2 weeks ago
USANA Health Sciences, Inc. (USNA) Q3 2024 Earnings Call Transcript USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2024 Earnings Call Transcript October 23, 2024 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Douglas Hekking - CFO Brent Neidig - CCO Conference Call Participants Anthony Lebiedzinski - Fidelity Sidoti Linda Bolton Weiser - Davidson Operator Good day, and welcome to today's Usana Health Sciences Third Quarter Earnings Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. seekingalpha.com - 3 weeks ago
USANA Health Sciences (USNA) Q3 Earnings Surpass Estimates USANA Health Sciences (USNA) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago. zacks.com - 3 weeks ago
USANA Health Sciences Reports Third Quarter 2024 Results SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 28, 2024. Key Financial & Operating Results Third quarter net sales were $200 million versus $213 million during Q3 2023. Third quarter diluted EPS was $0.56 as compared with $0.59 during Q3 2023. Company updates fiscal year 2024 net sales and diluted EPS outlook to approximately $850 million and $2.45, respectively (previously $850 million. businesswire.com - 3 weeks ago
10 small-cap stocks selected by digging deep for quality David Trainer explains how New Constructs incorporates decades of information buried in companies' financial statement notes, for “better” calculations of returns on invested capital marketwatch.com - 1 month ago
11 USANA Products Now Listed on Prestigious Prescribers' Digital Reference® SALT LAKE CITY , Oct. 10, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. is proud to announce that the Prescribers' Digital Reference® (PDR) has recently included 11 of USANA's products to their list of trusted drugs and supplements. This recognition adds further credibility to the world-renowned quality of USANA's products while placing supplemental facts directly in the hands of prescribers. prnewswire.com - 1 month ago
USANA Schedules Third Quarter 2024 Earnings Release and Conference Call SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2024 results will be released after the close of market on Tuesday, October 22, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and inst. businesswire.com - 1 month ago
USANA Executive Chairman Kevin Guest Celebrates Country Music Month, Mental Balance SALT LAKE CITY , Oct. 1, 2024 /PRNewswire/ -- As vibrant melodies of Country Music Month fill the air this October, there is no better time to explore the symphony between our love for music and the pursuit of mental wellness. Country music, with its rich storytelling and emotional resonance, offers more than just a soundtrack to our lives—it serves as a guiding force in achieving mental well-being, according to Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA). prnewswire.com - 1 month ago
USANA-Sponsored Olympic and Paralympic Athletes Take Home 99 Combined Medals 40 Gold, 33 Silver, and 26 Bronze won SALT LAKE CITY , Sept. 19, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. would like to congratulate all 265 sponsored USANA Athletes who competed at the 2024 Summer Olympic and Paralympic Games in Paris. prnewswire.com - 1 month ago
USANA Executive Chairman Kevin Guest Celebrates Entrepreneurs in Today's Business World SALT LAKE CITY , Sept. 3, 2024 /PRNewswire/ -- Entrepreneurs play a critical role in driving innovation, economic growth, and stability, according to Kevin Guest, executive chairman at USANA Health Sciences, a global leader in health and wellness products. prnewswire.com - 2 months ago
USANA Launches New, Innovative Skincare and Protein Products Resurfacing Serum and Whey Protein Isolate up the game for USANA SALT LAKE CITY , Aug. 19, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. has recently added two new products to its line of high-quality, science-based products. Celavive Resurfacing Serum blends powerful, clinically proven ingredients formulated to visibly transform the look of your skin. prnewswire.com - 2 months ago
8. Profile Summary

USANA Health Sciences, Inc. USNA

image
COUNTRY US
INDUSTRY Packaged Foods
MARKET CAP $ 769 M
Dividend Yield 0.00%
Description USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Contact 3838 West Parkway Boulevard, Salt Lake City, UT, 84120 https://www.usana.com
IPO Date April 4, 1994
Employees 1800
Officers Mr. Patrique Richards Executive Director of Investor Relations & Business Development Peter Benedict Chief Information Officer Mr. Walter Noot Chief Operating Officer Mr. Daniel A. Macuga Jr. Chief Communications & Marketing Officer Mr. G. Douglas Hekking Chief Financial Officer Dr. John Cuomo Executive Director of Product Development & Technology Mr. Jim Brown Chief Executive Officer & President Dr. Myron W. Wentz Ph.D. Founder & Chairman Emeritus Dr. Robert A. Sinnott M.N.S., Ph.D. Chief Scientific Officer Mr. Kevin G. Guest Executive Chairman